The KLOW peptide protocol is a four-peptide blend combining GHK-Cu (50mg), KPV (10mg), BPC-157 (10mg), and TB-500 (10mg) into a single 80mg vial. It builds on the three-peptide GLOW protocol by adding KPV for enhanced anti-inflammatory action. It emerged from the observation that the GLOW protocol (GHK-Cu + BPC-157 + TB-500) worked well for tissue repair and skin rejuvenation but left one gap: it didn’t directly address systemic inflammation.
That’s a problem when healing needs to happen alongside an active inflammatory response. Think autoimmune flare-ups, chronic gut inflammation, or recovery from illness where the immune system is still running hot. BPC-157 and TB-500 both have anti-inflammatory properties, sure, but their primary mechanisms target tissue repair pathways. They reduce inflammation as a secondary effect.
KPV is different. It walks straight into the cell nucleus and shuts down NF-kB, the master switch controlling inflammatory cytokine production (Kannengiesser et al., Anti-Inflammatory Mechanisms, 2020). No other peptide in the GLOW stack does that.
Reviews
There are no reviews yet.